Unmutated IGHV CLL cells, on the other hand, have sustained BCR signalling by binding to multiple epitopes, resulting in a lower mutation burden and a higher driver mutation frequency. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.